• SENSEX 76,909.68
    -325.78 (--0.42%)
  • BANKNIFTY 57,262.40
    -235.40 (--0.41%)
  • Aster DM Quality
    766.10 519.80(%)
  • Dhoot Transmission
    1,436.85 1,306.25(%)
  • Oberoi Realty
    1,831.50 1,390.15(%)
  • Abbott India
    26,302.50 25,164.00(%)
  • Pfizer
    4,965.00 5,878.55(%)
  • Cupid
    291.00 298.95(%)
  • Cyient
    902.75 1,282.40(%)
  • HDFC Bank
    715.05 722.00(%)
  • Netweb Technol.
    5,024.00 2,037.65(%)
  • Himadri Special
    702.00 420.00(%)
  • SBI
    1,041.30 798.60(%)
  • Reliance Industries
    1,304.00 1,250.55(%)
  • Bharti Airtel
    1,921.35 1,745.00(%)
  • Kaynes Tech
    3,825.00 7,705.00(%)
  • Alkem Lab
    5,369.15 5,085.00(%)
  • Molbio Diagnosti
    1,013.65 925.80(%)
  • ICICI Bank
    1,391.10 1,187.55(%)
  • Vedant Fashions
    545.15 794.55(%)
  • Triveni Turbine
    561.35 428.50(%)
  • Power Fin.Corpn.
    376.50 486.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kopran Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Parijat
  • BSE Code : 2717.0
  • ISIN : INE082A01010
201.51 2 (0.90%)
  • As on 19 Aug 2026 (EOD)

  • Today’s Low

    199.51

  • Today’s High

    208.50

  • Open

    201.69

  • Perv Close

    199.71

  • 52W Low

    107.00

  • 52W High

    219.00

Key Indicators

  • P/E(TTM)

    28.82

  • Mar.Cap (₹Cr.)

    973.00

  • Div & Yield %

    1.50

  • Book Value(₹)

    92.75

  • Debt-Equity Ratio

    0.90

  • AGM Date

    18-Aug-2026

  • EPS

    6.96

  • P/E Ratio

    28.82

Financials Ratios

  • Debt-Equity Ratio

    0.19

  • Mar.Cap (₹Cr.)

    973.00

  • RONW (%)

    10.95

  • ROCE (%)

    13.57

Score Board

  • Equity (₹ in Cr.)

    48.29

  • BV (₹)

    92.70

  • Sales( ₹ in Cr.)

    305.65

  • NP (in Cr.)

    30.40

  • NP Var(%)

    13.0

  • Div%

    30.0

  • CPS (₹)

    7.30

  • EPS (₹)

    6.30

  • Traded Value (₹ in Lakhs)

    968.61

  • 52 Week High

    219.00

  • 52 Week Low

    107.00

  • Price BSE

    201.0

  • Price NSE

    202.00

  • Market Capital( in Cr.)

    968.61

  • P/C Ratio

    27.40

  • P/E Ratio

    31.90

  • Price Vs.BV

    6.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 305.65 271.01 337.46 273.09 204.52 222.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 305.65 271.01 337.46 273.09 204.52 222.83
Other Income 2.00 5.90 16.71 16.09 8.03 10.41
Stock Adjustments -3.79 1.84 1.74 -3.55 3.93 -14.70
Total Income 303.86 278.75 355.91 285.63 216.48 218.54
EXPENDITURE :            
Raw Materials 166.35 159.22 231.89 174.14 131.75 123.04
Power and Fuel Cost 9.69 8.59 7.89 7.58 6.51 5.68
Employee Cost 32.94 30.02 25.61 25.15 21.05 18.34
Other Manufacturing Expenses 14.10 12.56 12.45 10.69 9.75 8.33
Selling and Administration Expenses 24.46 21.35 22.45 20.85 22.65 19.79
Miscellaneous Expenses 6.75 2.46 1.98 3.23 1.31 2.75
Employee Benefit Expenses 32.94 30.02 25.61 25.15 21.05 18.34
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 254.29 234.19 302.26 241.63 193.03 177.93
Operating Profit 49.58 44.56 53.64 44.00 23.44 40.62
Interest 4.20 3.77 4.50 2.67 2.95 3.81
Gross Profit 45.38 40.79 49.14 41.33 20.49 36.81
Depreciation 4.98 5.00 4.62 4.41 4.32 4.10
Profit Before Tax 40.40 35.79 44.52 36.92 16.17 32.71
Current Tax 9.04 8.63 10.08 5.87 3.75 5.76
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.96 0.31 -0.20 -0.21 0.67 3.48
Reported Net Profit 30.40 26.86 34.64 31.25 11.74 23.47
Extraordinary Items 0.00 0.00 -0.01 0.00 0.00 -0.01
Adjusted Net Profit 30.40 26.86 34.65 31.25 11.74 23.48
Adjustment below Net Profit 0.41 0.06 0.00 0.00 0.00 0.00
P & L Balance brought forward 111.83 99.38 79.20 62.41 57.15 40.17
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 14.49 14.46 14.46 14.46 6.49 6.49
P & L Balance carried down 128.15 111.83 99.38 79.20 62.41 57.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 30.00 30.00 30.00 30.00 30.00
Dividend Per Share(Rs) 3.00 3.00 3.00 3.00 3.00 3.00
Earnings Per Share-Unit Curr 6.30 5.56 7.18 6.48 2.44 5.43
Earnings Per Share(Adj)-Unit Curr 6.30 5.56 7.18 6.48 2.44 5.43
Book Value 92.75 89.35 86.47 82.05 78.56 57.07
Book Value(Adj)-Unit Curr 92.75 89.35 86.47 82.05 78.56 57.07

Shareholding Pattern

  • Promoter Group

    44.42%

  • Public Share Holding

    55.58%

  • Custodian

    0.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 17,795,993 36.86 17,795,993 6
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,653,210 7.57 3,653,210 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,449,203 44.42 21,449,203 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 247,662 0.51 247,662 15
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 300 0.00 0 3
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,575 0.00 1,075 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 600 0.00 300 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 250,137 0.52 249,037 27
2] Non Institution
Bodies Corporate 2,631,856 5.45 2,612,256 291
Clearing Members 268,089 0.56 268,089 26
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,152,688 2.39 1,152,538 905
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,218,987 2.52 1,218,987 1,292
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,971,455 10.30 4,971,455 75
Individuals holding nominal share capital up to Rs. 1 lakh 16,339,242 33.84 16,103,319 54,296
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,948 0.00 1,948 2
Others 1,500 0.00 1,500 1
Sub Total 26,585,765 55.06 26,330,092 56,888
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 500 0.00 500 1
Total Shares held by Custodians and against which Depository Receipts have been issued 500 0.00 500 1
Grand Total ( A + B + C ) 48,285,605 100.00 48,028,832 56,925

Company Background

Kopran LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Kopran Ltd
  • BSE Code : 2717.0
  • ISIN : INE082A01010

  • Incorporation Year

    1958

  • Registered Office

    Parijat House 1076
    Dr E Moses Road Worli, Mumbai,
    Maharashtra-400018

  • Telephone

    91-22-43661111

  • FAX

    91-22-24950363

  • Chairman

    Surendra Somani

  • Managing Director

    Surendra Somani

  • Company Secretary

    Sunil Sodhani

  • Auditor

    Khandelwal Jain & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Kopran Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kopran 200.60 307.65 305.65 28.82 9.10
Abbott India 26,587.05 7,217.19 6,929.05 34.99 43.78
Astrazeneca Phar 7,649.85 2,304.07 2,275.58 112.75 27.86
Glaxosmi. Pharma 2,883.20 3,932.76 3,790.20 46.06 58.17
Novartis India 1,594.05 398.23 356.27 40.25 16.64
Cipla 1,431.85 20,102.60 18,979.95 37.63 13.88
Bliss GVS Pharma 545.45 773.53 729.81 50.65 12.51
Amrutanjan Healt 488.65 469.50 451.82 26.17 21.89
Fermenta Biotec. 454.50 474.15 450.25 21.22 18.77
Guj. Themis Bio. 372.35 152.47 150.80 83.30 27.21
Ambalal Sarabhai 47.70 19.52 3.94 88.33 6.77